Home Pilots Abbott’s implantable cardiac monitor CardioMEMS lands expanded FDA designation Pilots Abbott’s implantable cardiac monitor CardioMEMS lands expanded FDA designation By - February 22, 2022 102 0 Facebook Twitter Pinterest WhatsApp The system first landed clearance in 2014 for Class III heart failure patients. RELATED ARTICLESMORE FROM AUTHOR Pilots Former Ripple exec Greg Kidd buys Know Labs with Bitcoin Pilots RadNet acquires See-Mode Technologies for access, revenue growth Pilots FDA launches AI tool for its employees LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Employer-focused pharmacy benefits company Truveris raises $15M Pilots - May 14, 2024 0 Ring-type sensor in Singapore measures skin feel Pilots - April 29, 2024 0 Clinical trial recruitment platform SubjectWell scores $35M Pilots - October 24, 2022 0 Menopause care platform Gennev becomes Aetna in-network provider Pilots - May 16, 2023 0 Transcarent raises $126M, bringing its valuation to $2.2B Pilots - May 2, 2024 0 POPULAR CATEGORIESPilots2369Applications835Testing285Collaborations15GitHub3